Medidata Study Experience

31. Automated Trial Monitoring Workflows Make Small Teams More Efficient 4/13/2023

    A pharmaceutical therapy developer was looking to automate reports, confirmation letters, and follow-up letters. See what happened when they adopted a cloud-based solution for end-to-end trial management.

32. Achieving Harmonious and Optimized Site Budget Negotiations 4/13/2023

    Review findings from research efforts into how principal investigators survive the complex process, identify coping strategies, and combat budget negotiation challenges.

33. Synthetic Control Arm®: The Smart External Control Arm Solution 3/14/2023

    Find out how you can bring significant value to your company’s clinical trials and ultimately increase the probability of overall success of your key pipeline assets.

34. How To Double High-Performing Site Count In A Priority Indication 3/13/2023

    A top 10 biopharmaceutical company wanted to expand its site list in a priority indication and better understand how existing sites in their database performed. Find out what happened next.

35. The State Of Black Participation In Clinical Trials 2/24/2023

    The need to design trials enrolling more demographically diverse patients is widely recognized. Learn why implementing effective, sustainable, and scalable enrollment diversity strategies remains a challenge for biopharmaceutical companies.

36. Intelligent Trials - Diversity 2/17/2023

    Medidata AI’s Intelligent Trials solution provides insights that allow you to take action to improve study diversity during the planning stages.

37. New Therapeutic And Diagnostic Avenues In Breast Cancer 1/24/2023

    This podcast discusses an important metastatic breast cancer study that was recently published in the New England Journal of Medicine and presented at ASCO - the American Society of Clinical Oncology in June 2022.

38. A New Avenue In Breast Cancer Therapeutics 1/23/2023

    Clinical trial findings may have unlocked a groundbreaking opportunity for breast cancer patients: beneficial therapy for HER2-negative patients with HER2-directed antibody-drug conjugates.

39. Rave eTMF - Simplify Trial Oversight With Unified Document Management 1/2/2023

    Your Trial Master File (TMF) complexity is growing. It’s not uncommon to upload thousands of documents per day, subject to strict regulatory requirements for filing, and under aggressive timelines. Rave eTMF is a global, secure collaboration platform to seamlessly manage Trial Master File content so it is always contemporaneous with the study.

40. 3 Data Linkage Use Cases To Future Proof Your Clinical Trials 12/20/2022

    Discover why access to compelling and relevant evidence is crucial to drug development, safety monitoring, and improved patient outcomes.